The Daily Bolus

  • The Daily Bolus: The Triple Agonist Showdown & Surprising GLP-1 Wins in Type 1 Diabetes

    Welcome to today’s edition of The Daily Bolus! The incretin landscape is rapidly evolving into the era of the “triple agonist,” with Eli Lilly and Novo Nordisk going head-to-head to push weight loss and A1C reduction to new extremes. Meanwhile, groundbreaking real-world data is showing that these blockbuster therapies are quietly transforming long-term care for…

  • The Daily Bolus: Red Cell Sponges, Microbiome Signatures, and Cyborg Cells

    Today’s research is moving beyond the traditional “big three” of glucose disposal—liver, muscle, and fat. We explore how red blood cells can be recruited as metabolic “sponges,” how AI-driven gut signatures are catching insulin resistance earlier than ever, and why an electronic “cyborg” mesh might be the key to making lab-grown pancreatic cells finally function…

  • The Daily Bolus: Retinopathy Pills, Diabetes Risk Watches, and Immune Fixes for Insulin Resistance

    The diabetes pipeline is starting to look a lot like the cardiovascular playbook: prevent early, intervene earlier, and push treatment upstream before irreversible damage begins. This week’s updates span three very different corners of the ecosystem — but they share the same underlying theme. We’re seeing credible attempts to (1) stop complications before they become…

  • The Daily Bolus: Early Warnings, Genetic Cloaks, and the Seven-Year Shield

    Whilst the title of this edition sounds like something out of  science fiction, in it we see a masterclass in “biological intelligence.” As of February 5, 2026, the signal cutting through the noise has shifted from hardware on the skin to the deep cellular architecture of the body. From “immune niches” that act as early-warning…

  • The Daily Bolus: Mechanism over metrics, biology over dashboards

    The developments highlighted in the bolus today reinforce a theme Diabettech has been circling for years: the most meaningful progress in diabetes does not come from squeezing ever more signal out of glucose curves, but from understanding the biology that sits underneath them. Not all of these are from the past 24 hours, but all…

  • The Daily Bolus: Et tu, B Cells?

    Recent news has been defined by a pivot toward “biological intelligence.” As of January 21, 2026, the signal cutting through the noise isn’t just about managing the disease after it arrives, but about uncovering the “hidden” sabotage within our immune systems and identifying at-risk children before the first symptom ever appears. 1. The “Sinister” Saboteurs:…